Profile data is unavailable for this security.
About the company
Beijing Foyou Pharma Co Ltd, formerly Beijing Winsunny Pharmaceutical Co Ltd, is a China-based company mainly engaged in the research, development, production and sales of pharmaceutical preparations and medical devices. The Company's pharmaceutical preparations mainly cover the fields of cardiovascular system, chronic kidney disease, skin disease, digestive system, diabetes, mental nervous system, gynecology and others. The Company's pharmaceutical preparation products mainly include tablets, ointments, creams, gels, soft capsules, solutions, syrups, tinctures, sprays, hard capsules and others. The Company's medical device business focuses on humidification and oxygen inhalation devices, and its main products include disposable oxygen inhalation tubes and others. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in CNY (TTM)3.42bn
- Net income in CNY510.00m
- Incorporated1999
- Employees3.44k
- LocationBeijing Foyou Pharma Co LtdBEIJING 101113ChinaCHN
- Phone+86 1 059603941
- Fax+86 1 059603942
- Websitehttp://www.foyou.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Animal Husbandry Industry Co., Ltd | 5.43bn | 87.90m | 6.96bn | 4.33k | 79.24 | 1.27 | -- | 1.28 | 0.0861 | 0.0861 | 5.31 | 5.37 | 0.6127 | 4.56 | 3.76 | 1,254,216.00 | 0.7085 | 6.23 | 1.00 | 9.01 | 16.42 | 24.29 | 1.16 | 8.69 | 1.54 | -- | 0.1909 | 31.20 | -8.24 | 4.04 | -26.73 | -0.6127 | 24.20 | -3.77 |
| JiangSu WuZhong Pharmactcl Devlpm Co Ltd | 2.38bn | -37.82m | 6.97bn | 1.05k | -- | 3.88 | -- | 2.92 | -0.055 | -0.055 | 3.34 | 2.52 | 0.5684 | 17.73 | 2.04 | 2,270,402.00 | -0.8772 | -2.92 | -1.79 | -5.30 | 28.07 | 28.14 | -1.54 | -5.77 | 1.46 | 0.5127 | 0.4841 | -- | 10.55 | 5.65 | 5.58 | -- | -19.08 | -- |
| Sichuan Huiyu Pharmaceutical Co Ltd | 1.12bn | 278.20m | 6.98bn | 1.36k | 25.09 | 1.80 | -- | 6.23 | 0.6567 | 0.6567 | 2.64 | 9.16 | 0.2335 | 1.18 | 21.25 | 820,954.90 | 5.66 | 10.41 | 7.08 | 12.76 | 83.40 | 89.89 | 24.23 | 21.42 | 2.57 | -- | 0.1488 | 20.54 | -37.92 | 76.37 | -43.86 | -- | 66.72 | -- |
| Zhejiang Ausun Pharmaceutical Co Ltd | 835.23m | 257.55m | 6.98bn | 1.17k | 27.03 | 3.04 | -- | 8.36 | 0.3111 | 0.3111 | 1.01 | 2.76 | 0.2788 | 1.09 | 2.84 | 711,439.10 | 8.60 | 9.38 | 11.35 | 12.84 | 54.34 | 53.09 | 30.84 | 27.14 | 2.00 | -- | 0.156 | 23.53 | 6.83 | 27.35 | 7.87 | 42.07 | 24.32 | 50.48 |
| Jinyu Bio-Technology Co Ltd | 1.35bn | 164.86m | 7.46bn | 1.65k | 44.89 | 1.37 | -- | 5.53 | 0.1484 | 0.1484 | 1.21 | 4.84 | 0.197 | 2.10 | 1.62 | 816,227.80 | 2.36 | 4.82 | 2.74 | 5.68 | 54.60 | 58.78 | 11.97 | 19.91 | 3.12 | -- | 0.0079 | 36.41 | 4.55 | -3.37 | 34.63 | -17.77 | -12.92 | -25.56 |
| Beijing Foyou Pharma Co Ltd | 3.42bn | 510.00m | 7.53bn | 3.44k | 14.78 | 2.12 | -- | 2.20 | 1.06 | 1.06 | 7.13 | 7.39 | 0.7622 | 3.64 | 9.70 | 996,443.00 | 11.43 | -- | 14.76 | -- | 65.53 | -- | 14.99 | -- | 2.73 | -- | 0.0245 | -- | 3.07 | -- | 11.36 | -- | -- | -- |
| Shanghai Haoyuan Chemexpress Co Ltd | 2.12bn | 152.63m | 7.74bn | 3.37k | 50.70 | 2.86 | -- | 3.64 | 0.7235 | 0.7235 | 10.06 | 12.84 | 0.4823 | 1.00 | 3.71 | 629,969.20 | 3.42 | 7.38 | 4.66 | 9.60 | 44.42 | 47.03 | 7.08 | 13.53 | 1.01 | 4.45 | 0.3229 | 14.37 | 38.44 | 44.33 | -34.18 | 47.24 | 48.95 | -- |
| Shandong Lukang Pharmaceutical Co Ltd | 6.08bn | 400.68m | 7.89bn | 6.48k | 19.82 | 2.03 | -- | 1.30 | 0.443 | 0.443 | 6.83 | 4.33 | 0.6850 | 3.39 | 6.92 | 937,972.80 | 4.66 | 2.21 | 7.60 | 4.05 | 22.74 | 23.41 | 6.80 | 3.46 | 0.8266 | 4.48 | 0.4744 | 31.79 | 9.34 | 13.04 | 78.37 | 8.81 | -16.95 | 23.94 |
| Shanghai Yizhong Pharmaceutical Co Ltd | 250.66m | 65.60m | 7.97bn | 43.00 | 122.45 | 5.52 | -- | 31.79 | 0.3163 | 0.3163 | 1.21 | 7.02 | 0.1669 | 0.5372 | 2.00 | 5,829,320.00 | 4.37 | -0.9181 | 4.57 | -0.9485 | 94.00 | 93.19 | 26.17 | -6.11 | 17.37 | -- | 0.0075 | -- | 52.68 | -- | 13.09 | -- | 20.44 | -- |
Data as of Nov 05 2024. Currency figures normalised to Beijing Foyou Pharma Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.91%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 05 Feb 2024 | 5.87m | 2.86% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 615.40k | 0.30% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 325.80k | 0.16% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2024 | 259.90k | 0.13% |
| Acadian Asset Management LLCas of 30 Sep 2024 | 246.60k | 0.12% |
| Fidelity Management & Research Co. LLCas of 31 Aug 2024 | 227.85k | 0.11% |
| Orient Fund Management Co., Ltd.as of 30 Jun 2024 | 187.90k | 0.09% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 125.20k | 0.06% |
| Changsheng Fund Management Co., Ltd.as of 30 Jun 2024 | 105.00k | 0.05% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 61.40k | 0.03% |
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
